ABSTRACT
Otomycosis is one of the common otologic conditions requiring medical consult and therapy. Most otomycosis isolates include Aspergillus or Candida spp. 1, 2 Clinical presentation may include intractable itching of the external auditory canal, otalgia, tinnitus and ear discharge. 3, 4 Physical examination reveals an erythematous canal with black, gray or white fungal elements (Figure 1 ). Direct microscopy using 10% KOH confirms the diagnosis. 5 Treatment often requires mechanical cleansing and 1-2 weeks application of topical antifungal agents. 6, 7 Clotrimazole 1% cream is commonly prescribed, providing symptom relief within 2 weeks in 96% of patients. 8 Other antifungal drops or powder medications (clotrimazole and nystatin) are also effective in many cases. 9, 10 Of the 10 locally available medicinal plants in the priority list of the Philippine Council for Health Research and Development (PCHRD) of the Department of Science and Technology (DOST) and Plant Resource of South East Asia (PROSEA), kalachuchi {Plumeria acuminata Ait.) has one of the highest activities in assays against Candida species. Antimycotic properties of kalachuchi (Plumeria acuminata Ait.) bark extract against Aspergillus flavus and Aspergillus niger have been shown in in-vitro studies. 12 Application of this extract in controlled and limited number of subjects may help establish its pharmacotherapeutic potentials.
The objective of this study was to compare the therapeutic efficacy of kalachuchi (Plumeria acuminata Ait.) bark extract ointment (KO) and the standard clotrimazole cream 1% (CC) in the treatment of otomycosis.
METHODS

Design:
Randomized double blind controlled trial. The study was reviewed and approved by the ethics committee of the Western Visayas Medical Center.
Setting: Outpatient otorhinolaryngology clinic in a tertiary private hospital.
Subjects: Voluntary, informed consent was obtained from 18 patients aged 18 to 70 years with otomycosis defined as presence of itchiness, ear pain, ear discharge, ear fullness or hearing impairment with otoscopic findings of external auditory canal erythema, discharge and fungal elements, testing positive on KOH smear were included in the study. Ten percent KOH smears were performed on swabs taken from the affected ear canal. In cases of bilateral otomycosis, the right ear was chosen for evaluation. Exclusion criteria were use of any topical otic medication and/or oral antifungal medication the past 30 days, presence of tympanic membrane perforation, concomitant otitis media, previous surgery on the test ear, history of hypersensitivity to clotrimazole and pregnant or lactating patients.
Intervention: Following thorough mechanical ear cleansing, patients were randomly assigned to the use of unlabeled containers of either clotrimazole cream 1% in group A or kalachuchi (Plumeria acuminata Ait.) bark extract ointment in group B. Details of kalachuchi bark extract preparation followed those previously described 12 and are available through corresponding author ( Figure 2) . A voucher specimen of the said kalachuchi was sent to a taxonomist and was positively identified as Plumeria acuminata Ait. After detailed instructions and demonstration, the topical agent was self-applied 3x a day for two weeks. Adverse events were monitored during the two-week treatment period. Patients with localized adverse effects such as hypersensitivity reactions, aural tenderness, formation of eczematous lesions and perichondritis were instructed to discontinue the test drug. Rescue drugs (antihistamines, analgesics or oral antibiotics) were administered to one such patient until events resolved. Patients who developed adverse effects, those with poor compliance to the assigned medication (use of <50% of the test drug) and those who did not wish to continue the treatment were further excluded from the study. 
RESULTS
Eighteen patients diagnosed clinically and microbiologically to have otomycosis were initially enrolled in the study comprising 9 test ears in each treatment group. Dropouts included one subject lost to follow up under CC treatment and one subject experiencing severe aural pain and tenderness under KO treatment. Sixteen patients with 8 patients in each treatment arm remained for analysis. These were 7 males and 9 females with a mean average age of 44 years.
The most common presentation of the patients upon consult was ear fullness (75%) and hearing impairment (75%) followed by itchiness of the affected ear (62.5%). On otoscopic examination, all patients had hyphal elements in the test ear. Fifty percent had ear canal erythema and only 34% had ear discharge. There was no significant difference between baseline characteristics of the two groups (Table 1) .
After 7 days of treatment, 37.5% of the subjects using CC and 25% of the subjects using KO reported symptom resolution. After two weeks, both groups had an equal incidence of patients (62.5%) who did not report any residual symptoms (Table 2) .
After one week of therapy, otoscopic examination revealed normal findings in 62.5% and 32.5% of subjects of the CC and KO groups, respectively. There was no statistically significant difference between the two treatment arms after 7 and 14 days of therapy (Table 2 ). It must be noted that in this study, the 62.5% response rate to the standard treatment CC requires a 0% response scenario to KO in order to establish a statistically significant difference.
After a week of treatment, only one patient (12.5%) in the KO group had a negative KOH smear while 50% of the CC group already showed absence of fungal elements. After two weeks of therapy, 75% and 87.5% had negative KOH smear for the KO and CC groups, respectively. The difference, however, was again not statistically significant (Table 2) .
Mild stinging of the involved ear canal was a common adverse reaction noted especially in the KO treatment. However, the intensity of the stinging was usually tolerable and was not strong enough to cause discontinuation of the treatment. There was only one patient who developed severe aural tenderness on the third day of treatment using KO, which caused her to discontinue the use of the said medication. Other adverse effects were not encountered with either treatment.
DISCUSSION
With its persistence and annoying symptoms, otomycosis can be a challenging and frustrating disease for both patient and otolaryngologist. With the increasing cost of commercially available antifungal agents, finding locally-available alternative herbal treatments can greatly help patients, especially the less affluent.
A previous in vitro study of the antifungal activity of four medicinal plants versus clotrimazole in the treatment of otomycosis showed that kalachuchi (Plumeria acuminata Ait.) bark extract using methylethylketone as solvent at 100% concentration was comparable in efficacy with the standard clotrimazole solution in treating Aspergillus flavus and Aspergillus niger. 12 This in vivo trial conducted to further determine the kalachuchi (Plumeria acuminata Ait.) bark extract's benefit as a topical antifungal agent against otomycosis showed no statistical significant difference between kalachuchi (Plumeria acuminata Ait.) bark extract ointment and clotrimazole cream 1% in terms of cure and complication rate. The cure rate for KO was 75% compared to 87.5% for CC. The results showed no significant difference between the two treatment groups based on chi-square analysis (Table 3 ). The failure rate for both treatment groups was relatively low (12.5% and 25%) for CC and KO, respectively (Table  3) . This may be due to residual fungal growth in the difficult-to-access antero-inferior recess near the tympanic membrane which may not be reached by topical medications in the form of creams and ointments as well as improper application of the medication. Other preparations for kalachuchi extract may need to be explored for ease of application.
While this preliminary study may suggest that KO may be as effective as the CC as an antifungal agent for otomycosis, to compare two proportions testing for efficacy of either treatment, a sample size of at least 88 for each treatment group is needed to test for statistically significant difference, accounting for treatment success in each arm and drop out rates. Complication rates should also be documented to establish the safety of kalachuchi bark extract compared to standard treatment. A multicenter study is needed to develop kalachuchi extract as an important antifungal agent for otomycosis. 
